Sensitisation for cisplatin-induced apoptosis by isothiocyanate E-4IB leads to signalling pathways alterations - Wikidata - wikimedia - TriplyDB

Sensitisation for cisplatin-induced apoptosis by isothiocyanate E-4IB leads to signalling pathways alterations

Sensitisation for cisplatin-induced apoptosis by isothiocyanate E-4IB leads to signalling pathways alterations

http://www.wikidata.org/entity/Q36611974

about

Sulforaphane induces cell cycle arrest by protecting RB-E2F-1 complex in epithelial ovarian cancer cells Sensitization of non-small cell lung cancer cells to cisplatin by naturally occurring isothiocyanates.Lipoplatin formulation review article.Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma Synergistic effect of allyl isothiocyanate (AITC) on cisplatin efficacy in vitro and in vivo.Anti-proliferative activity and cell cycle arrest induced by evodiamine on paclitaxel-sensitive and -resistant human ovarian cancer cells Isothiocyanate NB7M causes selective cytotoxicity, pro-apoptotic signalling and cell-cycle regression in ovarian cancer cells.Cytotoxic properties of Adamantyl isothiocyanate and potential in vivo metabolite adamantyl-N-acetylcystein in gynecological cancer cells.Description of the cytotoxic effect of a novel drug Abietyl-Isothiocyanate on endometrial cancer cell lines.Baker's Yeast Sensitizes Metastatic Breast Cancer Cells to Paclitaxel In Vitro.

P2860

Q33728766-9021C639-74CB-4CEC-B20E-164858115245 Q34076604-A08E086A-0C67-43AF-9BFE-780C58BA749A Q34214923-8057F488-E219-4DB3-B9E8-034C6AE9310D Q35143496-AD783F4E-05AF-4F6C-8A81-69562B0F24A0 Q36057163-1C3D8DDF-DB74-4DF1-92FB-8CF68254A351 Q36265840-01A72D7B-6864-40FA-84F9-40E70E9F29B6 Q37010601-8B154AA6-347E-4434-985C-19DAF81617CF Q39462960-42F27C82-405D-4BC7-93BE-4B9907A03383 Q39496590-CB10D3E1-5841-4ECE-B317-F93D98E5ADBE Q47434492-2CE371AA-72BF-4DD7-8D06-F3AB8D910D87

P2860

Sensitisation for cisplatin-induced apoptosis by isothiocyanate E-4IB leads to signalling pathways alterations

http://www.wikidata.org/entity/Q36611974

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Sensitisation for cisplatin-in ...... ignalling pathways alterations

@ast

Sensitisation for cisplatin-in ...... ignalling pathways alterations

@en

type

label

Sensitisation for cisplatin-in ...... ignalling pathways alterations

@ast

Sensitisation for cisplatin-in ...... ignalling pathways alterations

@en

prefLabel

Sensitisation for cisplatin-in ...... ignalling pathways alterations

@ast

Sensitisation for cisplatin-in ...... ignalling pathways alterations

@en

P1433

Q36611974-8E269C38-8EB4-4980-9844-690CED66A564

P1476

Q36611974-88C3512B-FD01-4C19-A5F3-5AD66BF8BF85

P2093

Q36611974-265F756B-FE70-4FAE-B46B-737DC9C84453

Q36611974-35D585CC-A5DA-49EC-9C81-E4F21292AD6F

Q36611974-55B2161B-DCF1-42EF-8FA8-3F40284F775A

Q36611974-660C4DE1-63F9-4A0F-BB54-C7B719190992

Q36611974-91AA7063-DA9F-4C87-A511-8E6EE115FDDF

Q36611974-AD47FF31-B6E6-40AA-B15B-02F337F25B9C

Q36611974-FF4D1E9B-FEF2-46BA-A324-8AB8E0975011

P2860

Q36611974-08462549-BB38-4CF3-A5C8-96204DE8E131

Q36611974-0BA6D4BC-8F80-4DF4-83B1-352E895A33CA

Q36611974-0E83324D-7F2C-44CB-A509-CDD1B7980845

Q36611974-10248D8A-334B-4449-85D9-A9F0344862D0

Q36611974-17587C55-B95D-46CE-982D-7BE4633E39CB

Q36611974-1C3C3827-F8E4-494D-BDD5-2DE4676E4953

Q36611974-29A4ACEE-4F5C-4270-80FB-6806FEF3CB83

Q36611974-404552F7-BE7C-4D3B-AA64-3B3F35BA458C

Q36611974-4A4A9012-63FD-4E2B-B9E6-4DD402C1B69C

Q36611974-4DC75FA8-E42C-403E-BDBC-EA27F4A4799A

P2888

Q36611974-644507B0-01A6-44CC-8A9D-58957510DE31

P304

Q36611974-A31059FC-D151-49C9-8BEB-0567116DEC7E

P31

Q36611974-585A4459-B5F8-4C73-986C-78386F728C55

P356

Q36611974-D7932BFD-465F-4935-8F9E-12040110A0FD

P407

Q36611974-645CFB25-8BE0-4CEF-8B05-6A5C4E39E762

P433

Q36611974-F7E591EC-605D-4EB9-9867-920BA0F56CF2

P478

Q36611974-6EE04116-A417-4DB5-996B-11D1ED6C9D55

P577

Q36611974-0A957242-2761-47E9-B184-746710F3FA52

P5875

Q36611974-BB500E46-C521-4A91-A63E-296D05828E2F

P6179

Q36611974-E175307C-FAF2-4E84-BB77-188A069C4629

P698

Q36611974-5E2D7FC0-A7A3-4DF5-B14E-0EC2CC77C84D

P932

Q36611974-EFEAE77C-1A18-445B-8061-8893B22BF05D

P356

P1433

British Journal of Cancer

P1476

Sensitisation for cisplatin-in ...... ignalling pathways alterations

@en

P2093

J Bodo

http://www.w3.org/2001/XMLSchema#string

J Duraj

http://www.w3.org/2001/XMLSchema#string

J Jakubikova

http://www.w3.org/2001/XMLSchema#string

J Kasparkova

http://www.w3.org/2001/XMLSchema#string

J Sedlak

http://www.w3.org/2001/XMLSchema#string

L Hunakova

http://www.w3.org/2001/XMLSchema#string

P Kvasnicka

http://www.w3.org/2001/XMLSchema#string

P2860

Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death

Cisplatin: mode of cytotoxic action and molecular basis of resistance

Cellular processing of platinum anticancer drugs

Phase I and pharmacological study of the farnesyltransferase inhibitor tipifarnib (Zarnestra, R115777) in combination with gemcitabine and cisplatin in patients with advanced solid tumours

Role of Gadd45 in apoptosis.

Regulation of the G2/M transition by p53.

Pharmacologic interruption of the mitogen-activated extracellular-regulated kinase/mitogen-activated protein kinase signal transduction pathway: potential role in promoting cytotoxic drug action.

p21-Mediated nuclear retention of cyclin B1-Cdk1 in response to genotoxic stress.

Cisplatin: from DNA damage to cancer chemotherapy.

Design of new anticancer therapies targeting cell cycle checkpoint pathways.

P2888

P304

1348-1353

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6603434

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P577

2006-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6735017

http://www.w3.org/2001/XMLSchema#string

P6179

1049702888

http://www.w3.org/2001/XMLSchema#string

P698

17060935

http://www.w3.org/2001/XMLSchema#string

P932

2360594

http://www.w3.org/2001/XMLSchema#string